CellaVision presents the second quarter 2015 on July 17 at 10

00 CET

The information was submitted to the public on July 1st, 2015 at 8:20 CET

CellaVision will publish the interim report for the second quarter on July 17, 2015 at 08:20 CET.

The report will be available at www.cellavision.com

In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 10:00 CET where Zlatko Rihter, CEO, will present and comment the report.

The presentation will be in English via a conference call or audio webcast: http://cloud.magneetto.com/wonderland/2015_0717_Cellavision_Q2_rapport ...

Phone number for the conference:
SE: [phone]
UK: [phone]
US: [phone]

No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time in order to facilitate a timely start.

For more information please contact:
Zlatko Rihter, CEO, CellaVision AB
Tel: [phone]. E-post: [e-mail]

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the mother company in Lund and by the market support organizations in the US, Canada, China and Japan. In 2014 sales were SEK 217 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at www.cellavision.com

Pdf

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CellaVision AB via Globenewswire

HUG#1932973